QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 maxim-group-maintains-buy-on-nephros-raises-price-target-to-6

Maxim Group analyst Anthony Vendetti maintains Nephros (NASDAQ:NEPH) with a Buy and raises the price target from $4.5 to $6.

 nephros-q2-eps-002-beats-003-estimate-sales-442m-beat-365m-estimate

Nephros (NASDAQ:NEPH) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.03) by 18...

 nephros-q1-eps-005-beats-001-estimate-sales-488m-beat-365m-estimate

Nephros (NASDAQ:NEPH) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 60...

 benchmark-reiterates-speculative-buy-on-nephros-maintains-5-price-target

Benchmark analyst Robert Wasserman reiterates Nephros (NASDAQ:NEPH) with a Speculative Buy and maintains $5 price target.

 nephros-q3-2024-gaap-eps-002-beats-002-estimate-sales-3500m-beat-3499m-estimate

Nephros (NASDAQ:NEPH) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 20...

 nephros-q3-sales-350m-inline
Nephros Q3 Sales $3.50M Inline
11/07/2024 22:01:49

Nephros (NASDAQ:NEPH) reported quarterly sales of $3.50 million which met the analyst consensus estimate. This is a 6.47 perce...

 nephros-q2-eps-003-misses-001-estimate-sales-325m-miss-386m-estimate

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.01) by ...

 benchmark-reiterates-speculative-buy-on-nephros-maintains-5-price-target

Benchmark analyst Robert Wasserman reiterates Nephros (NASDAQ:NEPH) with a Speculative Buy and maintains $5 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION